Phytochemical study of Homalanthus giganteus: isolation, antiproliferative activity, and computational mechanistic insights of tigliane diterpenes against colorectal cancer
Dyke Gita Wirasisya et al.
Abstract
Context
Colorectal cancer is the third most common and second deadliest cancer worldwide. Late diagnosis, poor outcomes in metastatic cases, and multidrug resistance emphasize the need for new therapies.
背景
结直肠癌是全球第三大常见癌症,也是第二大癌症死亡原因。确诊晚、转移性病例预后差以及多药耐药等问题,凸显了开发新疗法的迫切性。
Objective
This study aimed to isolate bioactive compounds from Homalanthus giganteus Zoll. ex Miq. (Euphorbiaceae), evaluate their antiproliferative effects on colorectal cancer cells, and identify mechanisms through network pharmacology and molecular docking.
目的
本研究旨在从 Homalanthus giganteus Zoll. ex Miq.(大戟科)中分离生物活性化合物,评估其对结直肠癌细胞的抗增殖作用,并通过网络药理学和分子对接阐明其作用机制。
Materials and methods
Compounds were isolated by chromatographic separations, and the structures were elucidated by NMR and HRESIMS. The antiproliferative activity was measured by MTT assay. DFT calculations were performed in ORCA 6.1.0. Network pharmacology was used to identify targets and pathways, molecular docking with AutoDock Vina was used to determine binding affinities, and pkCSM was applied to predict pharmacokinetics and toxicity.
材料与方法
采用色谱分离方法进行化合物分离,通过NMR和HRESIMS鉴定结构。抗增殖活性采用MTT法测定。DFT计算在ORCA 6.1.0中进行。利用网络药理学预测靶点和通路,采用AutoDock Vina进行分子对接以测定结合亲和力,并使用pkCSM预测药代动力学和毒性。
Results
7β-Hydroxysitosterol (1), 7α-hydroxysitosterol (2), 12-O-palmitoyl-phorbol-13-acetate (3), 12-O-palmitoyl-7-oxo-5-ene-phorbol-13-acetate (4), cerevisterol (5), and β-sitosterol-3-O-glucoside (6) were isolated from H. giganteus. Compound 4 exhibited the highest activity against Colo 205 (IC50 3.58 ± 0.37 μM) and Colo 320 cells (IC50 6.06 ± 1.70 μM) and higher DFT stability. Network pharmacology and docking study revealed kinase-specific targeting (STAT3, JUN, PRKCA, GSK3β), with 4 preferentially binds PRKCA/GSK3β, whereas 3 favors STAT3/JUN. The pkCSM prediction server predicted good oral bioavailability, CYP3A4 metabolism, limited CNS penetration, and acceptable toxicity for both diterpenes.
结果
从 H. giganteus 中分离得到6个化合物:7β-羟基谷甾醇(1)、7α-羟基谷甾醇(2)、12-O-棕榈酰基佛波醇-13-乙酸酯(3)、12-O-棕榈酰基-7-氧代-5-烯-佛波醇-13-乙酸酯(4)、脑甾醇(5)和β-谷甾醇-3-O-葡萄糖苷(6)。化合物4对Colo 205细胞(IC₅₀ 3.58 ± 0.37 μM)和Colo 320细胞(IC₅₀ 6.06 ± 1.70 μM)表现出最高的活性,且具有更高的DFT稳定性。网络药理学和分子对接研究揭示其具有激酶靶向特异性(STAT3、JUN、PRKCA、GSK3β),其中化合物4优先结合PRKCA/GSK3β,而化合物3倾向于结合STAT3/JUN。pkCSM预测服务器预测两种二萜类化合物均具有良好的口服生物利用度、经CYP3A4代谢、中枢神经系统渗透性低,且毒性在可接受范围内。
Discussion and conclusions
Six compounds were isolated from H. giganteus, with 4 exhibiting antiproliferative activity through PRKCA and GSK3β modulation. These findings provide the first phytochemical and mechanistic evidence that support H. giganteus as a promising source of active anti-colon cancer leads.
讨论与结论
从 H. giganteus 中分离得到6个化合物,其中化合物4通过调节PRKCA和GSK3β发挥抗增殖活性。这些发现首次提供了植物化学和机制方面的证据,支持 H. giganteus 作为抗结肠癌活性先导化合物有前景的来源。
Keywords: Homalanthus giganteus,Euphorbiaceae,tigliane diterpenoids,colorectal cancer,network pharmacology,molecular docking
关键词:Homalanthus giganteus;大戟科;巴豆烷型二萜;结直肠癌;网络药理学;分子对接
···
Experimental methods
General experimental procedures
Nuclear magnetic resonance (NMR) spectra were generated on Bruker Ascend 500 (500 MHz for 1H, 125 MHz for 13C), except for the 2D NMR spectra of 3 and 4 which were measured on Bruker AVANCE III 600 (600 MHz for 1H, 150 MHz for 13C) spectrometers (Bruker BioSpin, Germany). High-resolution electrospray ionization mass spectrometry (HRESIMS) was carried out on a Thermo Scientific Q Exactive Plus Orbitrap mass spectrometer (Thermo Fisher Scientific, USA), which was operated in positive or negative ionization mode. Centrifugal partition chromatography (CPC) was conducted on a pilot-scale (RPCC) (Rotachrom Technologies, Budapest, Hungary). Open column chromatography (OCC) was performed using silica gel 60 (0.045–0.063 mm; Molar Chemicals, Budapest, Hungary, Product No. CM0098429), polyamide (50–160 μm; MP Biomedicals, Irvine, USA, Product No. 0209602), and Sephadex LH-20 (25–100 μm bead size; Cytiva, Uppsala, Sweden, Product No. 17-0090-01) columns. Vacuum liquid chromatography (VLC) silica gel 60 (15–40 μm; Molar Chemicals, Budapest, Hungary, Product No. BX3394455 was used. Flash chromatography (FC) was done using a CombiFlash NextGen 300+ system (Teledyne ISCO, Lincoln, NE, USA) equipped with dual-wavelength UV (254/280 nm) and a photodiode array (PDA), using RediSep Rf Gold High-Performance silica columns (12 g; Teledyne ISCO, Product No. 69-2203-345). Rotary planar chromatography (RPC, Chromatotron) was performed on a Harrison Research Model 7924 T instrument (Harrison Research, Palo Alto, CA, USA) with silica gel 60 GF254 (Merck, Darmstadt, Germany, Product No. 1.07749.1000). Thin-layer chromatography (TLC) was carried out using precoated silica gel 60 F254 aluminum sheets (20 × 20 cm, 0.2 mm layer thickness; Merck, Product No. 1.05554.0001). The compounds were visualized under UV light (254 and 365 nm) and after spraying with concentrated sulfuric acid (cc. H2SO4) and heating at 105 °C for 3–5 min. For semipreparative and analytical high-performance liquid chromatography (HPLC), a Shimadzu LC-2010CHT system (Shimadzu, Kyoto, Japan) equipped with a UV-Vis detector was used. Semipreparative separations were achieved using a Phenomenex Kinetex C18 column (100 Å pore size, 5 μm particle size, 250 × 10 mm; Phenomenex, CA, USA, Product No.00G-4601-E0). For analytical separation, a Phenomenex Luna C8 column (100 Å, 5 μm, 250 × 4.6 mm, Phenomenex, CA, USA, Product No. 00 G-4249-EO) was used. Analytical grade solvents were supplied by Molar Chemicals Kft. (Halásztelek, Hungary): methanol (Product No. 05730-006-410), n-hexane (Product No. 06850-101-411), n-heptane (Product No. 06830-101-350), CH2Cl2 (Product No. 02592-101-350), ethyl acetate (Product No. 02930-101-411). Solvents for HPLC were purchased from VWR International Kft. (Debrecen, Hungary): cyclohexane (Product No. 83629.320), and methanol (Product No. 20864.320). The water was supplied by the Milli-Q Direct 3 UV pump (Merck, Darmstadt, Germany).

